Literature DB >> 10194603

Development of terbutaline sulfate sustained-release coated pellets.

K Umprayn1, P Chitropas, S Amarekajorn.   

Abstract

Sustained-release coated pellets containing terbutaline sulfate (TS) 1.8% w/w were prepared. The suitable core formulation that gave round-shape TS pellets was preformulated and was composed of microcrystalline cellulose:lactose 38.61%:57.92%, hydroxypropyl cellulose (HPC-M) 1.67%, and water 40%, respectively. The core pellets containing active drug were coated with various amounts of ethylcellulose (EC) and a combination of EC/HPC-M polymers. The effects of fluidized bed polymeric film coats on drug release were studied in vitro. The dissolution characteristics were also investigated. The release of the active drug decreased as the amount of EC increased. This may be due to water-insoluble EC film, leading to decreased permeability in water. In the case of the combination of EC/HPC-M, the release of the active drug increased as the amount of HPC-M in the coating solution increased. Since HPC-M is a water-soluble polymer, it may be suggested that formation of pores were increased in the coating layer. Among five coating formulas in this study, formulation 1 (F1) (at 1.1% EC concentration) shows a similar dissolution profile to Bricanyl Durules; however, lag time for the release occurred. In conclusion, the formulation that gave an insignificant release profile (p < .01) when compared with commercial product was the capsule containing F1 (at 1.1% EC concentration) mixed with uncoated pellets at a ratio of 7:1, and the release was found to be reproducible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194603     DOI: 10.1081/ddc-100102198

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Novel film modifiers to alter the physical properties of composite ethylcellulose films.

Authors:  Lai Wah Chan; Kang Teng Ong; Paul Wan Sia Heng
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

2.  Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.

Authors:  Wycliffe S Omwancha; Rama Mallipeddi; Brenda L Valle; Steven H Neau
Journal:  Int J Pharm       Date:  2012-11-28       Impact factor: 5.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.